Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810456 · ClinicalTrials.gov registry record · Phase 2
Transdiagnostic Cognitive Behavioral Treatment for Anxiety
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 359
- Enrollment target
NCT03810456: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT03810456 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 359 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03810456, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 359 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial examining the effectiveness of a transdiagnostic cognitive behavioral treatment (CBT) in improving Veterans' community reintegration and quality of life. Veterans with anxiety-based disorders, including posttraumatic stress, panic, social anxiety, and generalized anxiety disorders (with or without co-occurring depression) will be randomized to an intensive CBT (iCBT) treatment delivered over one weekend, standard CBT (sCBT) delivered over 12 weeks or treatment as usual (TAU). The study will also evaluate the potential of the compressed weekend format of iCBT in producing more rapid improvement in outcomes and increasing psychotherapy engagement compared with a standard psychotherapy format. Qualitative interviews will be conducted with Veterans who receive iCBT and their family members to examine how iCBT and environmental factors impacted their process of recovery.
Interventions
- BEHAVIORAL Intensive Cognitive Behavior Therapy (iCBT)
- BEHAVIORAL Standard Cognitive Behavior Therapy (sCBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 359 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2022-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03810456
The ClinicalTrials.gov registry entry for NCT03810456 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 359 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intensive Cognitive Behavior Therapy (iCBT) is the first listed.
NCT03810456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03810456 about?
NCT03810456 is a clinical study titled "Transdiagnostic Cognitive Behavioral Treatment for Anxiety". This study is a randomized controlled trial examining the effectiveness of a transdiagnostic cognitive behavioral treatment (CBT) in improving Veterans' community reintegration and quality of life. Veterans with anxiety-based disorders, including posttraumatic stress, panic, social anxiety, and gene...
What is the current status of trial NCT03810456?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 359 participants. The study started on 2018-08-01. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03810456?
The interventions under investigation include: Intensive Cognitive Behavior Therapy (iCBT) (BEHAVIORAL), Standard Cognitive Behavior Therapy (sCBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03810456?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.